companydata.dkcompanydata.dk

Cystotech Invest ApS: Financial statements 2024

CVR: 43238191

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

Cystotech Invest ApS (CVR 43238191) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -14,849 and a net result of DKK -14,849 compared with DKK -21,520 the year before. Equity in the 2024 report amounted to DKK 6,628,549. The solvency ratio was 99.9%.

Gross Profit
DKK -14,849
Profit/Loss
DKK -14,849
Equity
DKK 6,628,549
Total Assets
DKK 6,635,299
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024--15K-15K6.6M0
2023--22K-22K5.4M0

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

Cystotech Invest ApS: The 2023 annual report is outMay 31, 2024

Cystotech Invest ApS has published its annual report for 2023. Gross profit came to DKK -21,520, and the net result was DKK -21,520.

About Cystotech Invest ApS

Cystotech Invest ApS is a Danish company of the type Anpartsselskab based in Silkeborg, founded in 2022. The company is registered under the industry Investering for egen regning. The management consists of Morten Petersen. The board consists of Bo Wase, Flemming Frandsen, Morten Petersen and Ole Niels Jakob Jensen. The company's owners include WAP HOLDING ApS, MORTEN PETERSEN ApS and POUL CARSTENSEN HOLDING ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -24,281 and a net result of DKK -24,281 compared with DKK -14,849 the year before. Equity in the 2025 report amounted to DKK 8,804,268.

Source: annual report 2025, Danish Business Authority

Other financial years